$0.049
0.002[4.26%]
At close: Apr 26
Tryp Therapeutics
(OTCQB:TRYPF)Tryp Therapeutics Stock (OTC:TRYPF), Analyst Ratings, Price Targets, Predictions
Tryp Therapeutics Inc has a consensus price target of $1.5, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from Ladenburg Thalmann and Ladenburg Thalmann on January 5, 2023 and August 26, 2021. With an average price target of $0.75 between Ladenburg Thalmann and Ladenburg Thalmann, there's an implied 1430.61% upside for Tryp Therapeutics Inc from these 2 analyst ratings.
Analyst Firms Making Recommendations1
Ladenburg Thalmann
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Tryp Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/05/2023 | TRYPF | Buy Now | Tryp Therapeutics | $0.05 | 2961.22% | Ladenburg Thalmann | Michael Higgins | → $1.5 | Reiterates | → Buy | Get Alert |
| 08/26/2021 | TRYPF | Buy Now | Tryp Therapeutics | $0.05 | — | Ladenburg Thalmann | Michael Higgins | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Tryp Therapeutics (TRYPF)?
The latest price target for Tryp Therapeutics (OTCQB: TRYPF) was reported by Ladenburg Thalmann on January 5, 2023. The analyst firm set a price target for $1.50 expecting TRYPF to rise to within 12 months (a possible 2961.22% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tryp Therapeutics (TRYPF)?
The latest analyst rating for Tryp Therapeutics (OTCQB: TRYPF) was provided by Ladenburg Thalmann, and Tryp Therapeutics reiterated their buy rating.
When was the last upgrade for Tryp Therapeutics (TRYPF)?
There is no last upgrade for Tryp Therapeutics.
When was the last downgrade for Tryp Therapeutics (TRYPF)?
There is no last downgrade for Tryp Therapeutics.
When is the next analyst rating going to be posted or updated for Tryp Therapeutics (TRYPF)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tryp Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tryp Therapeutics was filed on January 5, 2023 so you should expect the next rating to be made available sometime around January 5, 2024.
Is the Analyst Rating Tryp Therapeutics (TRYPF) correct?
While ratings are subjective and will change, the latest Tryp Therapeutics (TRYPF) rating was a reiterated with a price target of $0.00 to $1.50. The current price Tryp Therapeutics (TRYPF) is trading at is $0.05, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.